Literature DB >> 16822361

Primary prevention for patients with intermediate Framingham risk scores.

Jason B Thompson, Juan J Rivera, Roger S Blumenthal, Peter Danyi.   

Abstract

Coronary heart disease (CHD) is the leading cause of mortality in the industrialized world. Proper identification of individuals at risk for CHD is challenging. The Framingham Risk Score, the most widely accepted tool for quantifying 10-year risk, fails to identify a great proportion of future CHD. Because of the health and economic consequences of CHD, there is a need to develop better prognostic tools for primary prevention. Coronary artery calcium scoring, C-reactive protein measurement, and heart rate recovery and exercise tolerance during exercise stress test may be useful tools for better risk stratification of intermediate-risk patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16822361     DOI: 10.1007/s11886-006-0056-4

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN: 1523-3782            Impact factor:   2.931


  35 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

2.  Prognostic value of cardiac risk factors and coronary artery calcium screening for all-cause mortality.

Authors:  Leslee J Shaw; Paolo Raggi; Enrique Schisterman; Daniel S Berman; Tracy Q Callister
Journal:  Radiology       Date:  2003-07-17       Impact factor: 11.105

3.  Coronary artery calcium: should we rely on this surrogate marker?

Authors:  Rita F Redberg
Journal:  Circulation       Date:  2006-01-24       Impact factor: 29.690

Review 4.  Comprehensive coronary risk determination in primary prevention: an imaging and clinical based definition combining computed tomographic coronary artery calcium score and national cholesterol education program risk score.

Authors:  Khurram Nasir; Chandra Vasamreddy; Roger S Blumenthal; John A Rumberger
Journal:  Int J Cardiol       Date:  2005-11-21       Impact factor: 4.164

5.  Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women: Beyond Endorsed Lipid Lowering with EBT Scanning (BELLES).

Authors:  Paolo Raggi; Michael Davidson; Tracy Q Callister; Francine K Welty; Gloria A Bachmann; Harvey Hecht; John A Rumberger
Journal:  Circulation       Date:  2005-07-11       Impact factor: 29.690

Review 6.  Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?

Authors:  Samia Mora; Paul M Ridker
Journal:  Am J Cardiol       Date:  2005-12-01       Impact factor: 2.778

7.  Predictive value of electron beam computed tomography of the coronary arteries. 19-month follow-up of 1173 asymptomatic subjects.

Authors:  Y Arad; L A Spadaro; K Goodman; A Lledo-Perez; S Sherman; G Lerner; A D Guerci
Journal:  Circulation       Date:  1996-06-01       Impact factor: 29.690

8.  Preventing myocardial infarction in the young adult in the first place: how do the National Cholesterol Education Panel III guidelines perform?

Authors:  Kwame O Akosah; Ana Schaper; Christopher Cogbill; Paul Schoenfeld
Journal:  J Am Coll Cardiol       Date:  2003-05-07       Impact factor: 24.094

9.  A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis.

Authors:  Subodh Verma; Chao-Hung Wang; Shu-Hong Li; Aaron S Dumont; Paul W M Fedak; Mitesh V Badiwala; Bikramjit Dhillon; Richard D Weisel; Ren-Ke Li; Donald A G Mickle; Duncan J Stewart
Journal:  Circulation       Date:  2002-08-20       Impact factor: 29.690

10.  Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells.

Authors:  Paolo Calabró; James T Willerson; Edward T H Yeh
Journal:  Circulation       Date:  2003-10-06       Impact factor: 29.690

View more
  1 in total

1.  Evidence of lung function for stratification of cardiovascular disease risk.

Authors:  Hwa Mu Lee; Steven T Truong; Nathan D Wong
Journal:  Korean Circ J       Date:  2011-04-30       Impact factor: 3.243

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.